Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer; Current Medical Research and Opinion Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Sunday, March 07, 2010

Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer; Current Medical Research and Opinion



Objective: To compare the efficacy of intranasal fentanyl spray (INFS), oral transmucosal fentanyl citrate (OTFC), fentanyl buccal tablet (FBT) and oral morphine (OM) for the treatment of breakthrough cancer pain (BTCP).

Conclusion: Based on currently available evidence, INFS is expected to provide the greatest improvement in the treatment of BTCP. Due to its slow onset to effect OM cannot be considered an efficacious treatment for BTCP.

2 comments :

  1. The nasal mucosa is highly vascularized AND it offers a direct path to the CSF via the olfacteory mucosa (nose-brain path). Any molecule that can cross the buccal or subligual mucosa will likely result in higher and faster CSF and blood levels if given via the nose (with an appropriate delivery device to ensure good mucosal coverage - not just dripping it in). Furthermore it works even in patients that have no saliva and who cannot swallow and it is easy tio deliver. Fentanyl is highly lipophilic and rapidly crosses into the body via the nose - the generic formulation is a little dilute for adults but is fantastic and cheap for treating pain in kids and some adults (see www.intranasal.net). Sufentanil generic formulation is well concentrated for adult cancer pain control (see data by Good et al). It is only a matter of time before clinicians recognize the nasal path as a simple, cost effective, very rapid route to treat breakthrough pain.

    ReplyDelete
  2. Contraindicated for those cancer patients undergoing angiogenesis treatments specifically Avastin (Bevacizumab) - other exceptions?

    ReplyDelete

Your comments?

Note: Only a member of this blog may post a comment.

2 comments :

  1. The nasal mucosa is highly vascularized AND it offers a direct path to the CSF via the olfacteory mucosa (nose-brain path). Any molecule that can cross the buccal or subligual mucosa will likely result in higher and faster CSF and blood levels if given via the nose (with an appropriate delivery device to ensure good mucosal coverage - not just dripping it in). Furthermore it works even in patients that have no saliva and who cannot swallow and it is easy tio deliver. Fentanyl is highly lipophilic and rapidly crosses into the body via the nose - the generic formulation is a little dilute for adults but is fantastic and cheap for treating pain in kids and some adults (see www.intranasal.net). Sufentanil generic formulation is well concentrated for adult cancer pain control (see data by Good et al). It is only a matter of time before clinicians recognize the nasal path as a simple, cost effective, very rapid route to treat breakthrough pain.

    ReplyDelete
  2. Contraindicated for those cancer patients undergoing angiogenesis treatments specifically Avastin (Bevacizumab) - other exceptions?

    ReplyDelete

Your comments?

Note: Only a member of this blog may post a comment.